deferasirox stada 360 mg
stada arzneimittel ag - germania - deferasiroxum - compr. film. - 360mg - alte preparate terapeutice chelatori de fer
deferasirox stada 90 mg
stada arzneimittel ag - germania - deferasiroxum - compr. film. - 90mg - alte preparate terapeutice chelatori de fer
emtricitabina/tenofovir disoproxil stada 200 mg/245 mg
remedica ltd - cipru - emtricitabinum+tenofovirum disoproxil - compr. film. - 200mg/245mg - antivirale cu actiune directa antivirale pentru tratamentul infectiei cu hiv, combinatii
caspofungina galenicum health 50 mg
pharmadox healthcare, ltd - malta - caspofunginum - pulb. pt. conc. pt. sol. perf. - 50mg - antimicotice de uz sistemic alte antimicotice sistemice
caspofungina galenicum health 70 mg
pharmadox healthcare, ltd - malta - caspofunginum - pulb. pt. conc. pt. sol. perf. - 70mg - antimicotice de uz sistemic alte antimicotice sistemice
caspofungina stada m&d 50 mg
sag munufacturing s.l. - spania - caspofunginum - pulb. pt. conc. pt. sol. perf. - 50mg - antimicotice de uz sistemic alte antimicotice sistemice
caspofungina stada m&d 70 mg
sag munufacturing s.l. - spania - caspofunginum - pulb. pt. conc. pt. sol. perf. - 70mg - antimicotice de uz sistemic alte antimicotice sistemice
kinpeygo
stada arzneimittel ag - budesonide, micronised - glomerulonephritis, iga - antidiareice, antiinflamatoare intestinale / antiinfective agenți - kinpeygo is indicated for the treatment of primary immunoglobulin a (iga) nephropathy (igan) in adults at risk of rapid disease progression with a urine protein-to-creatinine ratio (upcr) ≥1. 5 g/gram.
buprofess 400 mg
stada arzneimittel ag - germania - ibuprofenum - caps. moi - 400mg - antiinflamatoare si antireumatice nesteroidiene derivati de acid propionic
ximluci
stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologice - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).